InspireMD (NSPR) Research & Development (2010 - 2025)

InspireMD's Research & Development history runs 16 years deep, the most recent figure standing at $5.0 million for Q4 2025.

• On a quarterly basis, Research & Development fell 46.99% year-over-year to $5.0 million in Q4 2025; TTM through Dec 2025 was $15.2 million, a 1.48% increase from a year earlier, with the FY2025 full-year figure at $16.6 million, up 21.41% from the prior year.
• Research & Development grew to $5.0 million in Q4 2025 per NSPR's latest filing, from $3.6 million in the prior quarter.
• Across five years, Research & Development topped out at $9.5 million in Q4 2024 and bottomed at -$2.1 million in Q4 2023.
• The 5-year median for Research & Development is $1.4 million (2021), against an average of $2.0 million.
• Across the five-year window, Research & Development sank 203.38% in 2023 and surged 555.55% in 2024, its largest moves.
• Year by year, Research & Development stood at $1.5 million in 2021, then jumped by 31.23% to $2.0 million in 2022, then sank by 203.38% to -$2.1 million in 2023, then jumped by 555.55% to $9.5 million in 2024, then tumbled by 46.99% to $5.0 million in 2025.
• Per Business Quant, the three latest NSPR Research & Development figures stand at $5.0 million (Q4 2025), $3.6 million (Q3 2025), and $3.8 million (Q2 2025).